AllClear ID

AllClear ID is revolutionizing the management of patient identities in the healthcare industry with its patient-centric, mobile IDs that seamlessly travel with patients across various EHRs and care delivery channels. The company's flagship product, AllClear Health ID, effectively tackles the costly issue of patient record mismatching, amounting to a $6-9 billion annual burden on the industry. By leveraging mobile devices and direct EHR integrations, Health ID ensures the accurate alignment of patients with their medical records during registration, consistently. Furthermore, the solution complies with the highest privacy and compliance standards, including NIST Level 2 assurance for identity verification and authentication, HIPAA, and CCPA. Notably, the most recent investment in AllClear ID came from Experian in a Corporate Round investment on 31 March 2019. This innovative enterprise software, AllClear ID, effectively addresses a critical pain point within the healthcare industry, ushering in a new era of patient identification and record management. This is a substantial achievement as it aligns with the growing focus on digital health innovation and the prioritization of mobile-centric solutions. With its commitment to providing banking-grade security and unparalleled convenience, AllClear Health ID has the potential to significantly transform the healthcare landscape. Moreover, the backing of Experian further validates the company's strategy and potential for growth, solidifying its position as a compelling investment opportunity in the healthcare technology sector. For investors seeking exposure to disruptive technology with substantial market demand, AllClear ID presents a promising proposition within the enterprise software space.